Kim Blickenstaff - Tandem Diabetes Insider

TNDM -- USA Stock  

USD 26.93  1.04  4.02%

CEO and President and Director
Mr. Kim D. Blickenstaff is President, Chief Executive Officer, and Director of Tandem Diabetes Care, Inc. Prior to joining our company, he served as Chairman and Chief Executive Officer of Biosite Incorporated, or Biosite, a provider of medical diagnostic products, from 1988 until its acquisition by Inverness Medical Innovations, Inc. in June 2007. Mr. Blickenstaff currently serves as Chairman of Medivation, Inc., and is a member of its audit committee. He previously served as a director of DexCom, Inc., a provider of glucose monitoring systems, from June 2001 to September 2007
Age: 63  CEO Since 2007  MBA    
858-366-6900  http://www.tandemdiabetes.com
Blickenstaff was formerly a certified public accountant and has more than 20 years of experience overseeing the preparation of financial statements. He received a B.A. in Political Science from Loyola University, Chicago, and an M.B.A. from the Graduate School of Business, Loyola University, Chicago.

Kim Blickenstaff Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (27.78) % which means that it has lost $27.78 on every $100 spent on asset. This is way below average.
The company currently holds 76.41 M in liabilities with Debt to Equity (D/E) ratio of 644.8 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Tandem Diabetes Care has Current Ratio of 2.57 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Entity Summary

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States. Tandem Diabetes Care, Inc. was founded in 2006 and is headquartered in San Diego, California. Tandem Diabetes operates under Medical Devices classification in USA and traded on NASDAQ General Markets. It employs 574 people.Tandem Diabetes Care (TNDM) is traded on NASDAQ General Markets in USA. It is located in 11045 Roselle Street and employs 574 people.

Tandem Diabetes Care Leadership Team

Brian Hansen, President, MBA
Fred Cohen, Director
Susan Morrison, Executive
Lori Gildea, President, MBA
Howard Greene, Director, MBA
Christopher Twomey, Director
Henry Anhalt, Director
Edward Cahill, Director
Lonnie Smith, Chairman, MBA
John Cajigas, CFO
Dick Allen, Chairman, MBA
David Berger, Executive
Jesse Treu, Director, Ph.D
Richard Valencia, Director
Douglas Roeder, Director
Leigh Vosseller, President
John Sheridan, COO, MBA
Kim Blickenstaff, CEO, MBA
Robert Anacone, EVP

Stock Performance Indicators

Did you try this?

Run Coins and Tokens Correlation Now
   

Coins and Tokens Correlation

Utilize digital token correlation table to build portfolio of cryptocurrencies across multiple exchanges
All  Next Launch Coins and Tokens Correlation
Currently Active Assets on Macroaxis
DD   
Purchased over 100 shares of
few hours ago
Traded for 25.35
S   
Purchased over 500 shares of
few hours ago
Traded for 5.66
GOOG   
Purchased few shares of
few hours ago
Traded for 1188.8199
GM   
Purchased over 70 shares of
few hours ago
Traded for 39.36
GOOG   
Purchased few shares of
few hours ago
Traded for 1188.8199
Also please take a look at World Market Map. Please also try Price Transformation module to use price transformation models to analyze depth of different equity instruments across global markets.